Conference
Real-World Outcomes of Emicizumab in Hemophilia A with or without FVIII Inhibitors from the Canadian Hemophilia Bleeding Disorder Registry
Authors
Poon M-C; Lee A; Germini F; Keepanasseril A; Ibrahim Q; Nissen F; Moreno K; Santos M; Iserman E; Matino D
Volume
140
Pagination
pp. 8465-8467
Publisher
American Society of Hematology
Publication Date
November 15, 2022
DOI
10.1182/blood-2022-157531
Conference proceedings
Blood
Issue
Supplement 1
ISSN
0006-4971